Impact of Haemophilus influenzae Type b Conjugate Vaccine in Mongolia: Prospective Population-Based Surveillance, 2002-2010

Objectives Bacterial meningitis is associated with high mortality and long-term complications. This study assessed the impact of Haemophilus influenzae type b (Hib) conjugate vaccine on childhood bacterial meningitis in Ulaanbaatar, Mongolia. Study design Prospective, active, population-based survei...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of pediatrics 2013-07, Vol.163 (1), p.S8-S11
Hauptverfasser: Scott, Susana, PhD, Altanseseg, Dorjpurev, MD, PhD, Sodbayer, Demberelsuren, MD, MPH, Nymadawa, Pagvajav, MD, PhD, DSc, Bulgan, Davaadash, MD, PhD, Mendsaikhan, Jamsran, MD, PhD, Watt, James P., MD, MPH, Slack, Mary P.E., MA, MBBChir, FRCPath, Carvalho, Maria G., PhD, Hajjeh, Rana, MD, Edmond, Karen M., MBBS, MSc, MTPH, FRACP
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objectives Bacterial meningitis is associated with high mortality and long-term complications. This study assessed the impact of Haemophilus influenzae type b (Hib) conjugate vaccine on childhood bacterial meningitis in Ulaanbaatar, Mongolia. Study design Prospective, active, population-based surveillance for suspected meningitis in children aged 2-59 months was conducted (February 2002-January 2011) in 6 hospitals. Clinical data, blood, and cerebrospinal fluid were collected. The impact of Hib conjugate vaccine was assessed by comparing Hib and all cause meningitis data in the 3 years preceding pentavalent conjugate vaccine implementation (2002-2004) with 3 years postimplementation (2008-2010). Results Five hundred eleven cases of suspected meningitis were identified from 2002-2011. Pentavalent conjugate vaccine coverage in December 2005 in Ulaanbaatar city was 97%. The proportion of suspected cases confirmed as Hib meningitis decreased from 25% (50/201) in the prevaccination era to 2% (4/193) in the postvaccination era ( P  
ISSN:0022-3476
1097-6833
DOI:10.1016/j.jpeds.2013.03.024